急诊血清脂肪酶升高患者急性胰腺炎影像学表现的患病率
该回顾性研究纳入509例急诊脂肪酶≥3倍正常上限(≥180 U/L)患者,排除无影像、创伤、腹部转移、意识改变及外院转入后,最终分析188例。由两名腹部放射专科医师共识判读影像诊断AP,结果25.0%(47/188)有AP影像学表现。脂肪酶>10倍上限者影像阳性率34%,显著高于轻度升高者的16%(p=0.0042),脂肪酶水平与AP影像表现呈中度强相关(r=0.48,p<0.0001)。共识判读与原始放射报告不一致率为14.9%(28/188)。
要点
- 急诊脂肪酶≥3倍正常上限且接受影像检查的患者中,仅25.0%(47/188)存在AP影像学表现。
- 脂肪酶>10倍正常上限者AP影像阳性率为34%,高于脂肪酶≥3-10倍上限者的16%(p=0.0042)。
- 脂肪酶水平与AP影像学表现呈中度强相关(r=0.48,p<0.0001),脂肪酶越高影像阳性概率越大。
- 两名腹部放射专科医师共识判读与原始放射报告不一致率为14.9%(28/188),提示影像判读需谨慎。
- 该研究仅纳入脂肪酶≥3倍上限(≥180 U/L)且接受影像检查者,不能外推至未行影像或脂肪酶低于该阈值人群。
适用人群与场景
- 排除无影像检查(n=131)、创伤史、腹部转移、意识改变或外院转入(n=190)者,最终研究人群188例。
- 研究场景为急诊科,仅适用于脂肪酶≥3倍正常上限且接受影像检查的患者。
诊断标准与关键阈值
- 血清脂肪酶升高定义为≥3倍正常上限(≥180 U/L)。
- 脂肪酶分层:≥3-10倍正常上限与>10倍正常上限两组。
- AP诊断依据两名腹部放射专科医师对影像(CT/MRI)的共识判读。
- 原文未提及临床诊断标准、评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为回顾性单中心研究,最终样本188例,来自一家大型学术急诊科。
- 主要终点:25.0%(47/188)患者存在AP影像学表现。
- 脂肪酶>10倍正常上限组(n=94)AP影像阳性率34%,高于轻度升高组16%(p=0.0042)。
- 脂肪酶水平与AP影像学表现呈中度强相关(r=0.48,p<0.0001)。
- 次要终点:共识判读与原始放射报告不一致率为14.9%(28/188)。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
- 局限:回顾性设计、单中心、最终样本量188例、排除大量无影像及特定病史患者,结果仅适用于脂肪酶≥3倍正常上限且接受影像检查的急诊人群。
对床旁实践的改变
- 急诊脂肪酶≥3倍正常上限不等于AP,影像阳性率仅25.0%,应结合影像而非仅凭脂肪酶确诊。
- 脂肪酶>10倍正常上限者影像阳性概率更高(34%),可优先考虑影像评估。
- 影像判读存在不一致(14.9%),对不确定病例建议放射专科复核。
- 本研究不适用于未行影像检查、脂肪酶<3倍正常上限或有创伤/腹部转移/意识改变/外院转入的患者。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To assess the association of imaging features of acute pancreatitis (AP) with the magnitude of lipase elevation in Emergency Department (ED) patients.
METHODS: This Institutional Review Board-approved retrospective study included 509 consecutive patients presenting from 9/1/13-8/31/15 to a large academic ED with serum lipase levels ≥3× the upper limit of normal (ULN) (≥180 U/L). Patients were excluded if they did not have imaging (n = 131) or had a history of trauma, abdominal metastases, altered mental status, or transfer from an outside hospital (n = 190); the final study population was 188 patients. Imaging exams were retrospectively evaluated, and a consensus opinion of two subspecialty-trained abdominal radiologists was used to diagnose AP. Primary outcome was presence of imaging features of AP stratified by lipase level (≥3×-10× ULN and > 10× ULN). Secondary outcome was rate of discordant consensus evaluation compared to original radiologist's report.
RESULTS: 25.0% of patients (47/188) had imaging features of AP. When lipase was >10× ULN (n = 94), patients were more likely to have imaging features of AP (34%) vs. those with mild elevation (16%) (p = 0.0042). There was moderately strong correlation between lipase level and presence of imaging features of AP (r = 0.48, p < 0.0001). Consensus review of CT and MRI images was discordant with the original report in 14.9% (28/188) of cases.
CONCLUSION: Prevalence of imaging signs of AP in an ED population with lipase ≥3× ULN undergoing imaging is low. However, the probability of imaging features of AP increases as lipase value increases.
参考来源
- Glazer DI, Cochon LR, Raja AS, et al. Prevalence of imaging findings of acute pancreatitis in emergency department patients with elevated serum lipase. Am J Emerg Med. 2021. PMID: 34271230. doi:10.1016/j.ajem.2021.07.015
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。